Ethchlorvynol

Ethchlorvynol/ˌɛθklɒrˈvaɪnɒl/ is a sedative and hypnotic medication developed by Pfizer in the 1950s. In the United States it was sold by Abbott Laboratories under the tradename Placidyl. Placidyl was available in 200 mg., 500 mg., and 750 mg. strength capsules. While the 500 mg. and 750 mg. strength capsules were for use in reducing sleep latency, the 200 mg. strength capsules were intended to be used to re-induce sleep in case of early awakening. Abbott discontinued production in 1999, after which Placidyl was available for about a year in the United States. Although, theoretically, ethchlorvynol could be manufactured for sale in the United States by another pharmaceutical company (subject to FDA approval of such manufacture), no pharmaceutical company has chosen to do so.